Harnessing local and system immune profiling delineating differential responders to first-line sintilimab (anti-PD-1 antibody) combined with chemotherapy in extensive-stage small cell lung cancer: an exploratory biomarker analysis of a phase II study
利用局部和系统免疫特征分析来区分广泛期小细胞肺癌患者对一线信迪利单抗（抗PD-1抗体）联合化疗的不同反应：一项II期研究的探索性生物标志物分析
期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02252-5
Xie, Mengqing; Bao, Minwei; Dong, Xiaorong; Wu, Lin; Liu, Li; Zhao, Jing; Chu, Xiangling; Wu, Yan; Ji, Xianxiu; Fang, Yujia; Yu, Xin; Zhang, Shiji; Wang, Qi; Hu, Tao; Wang, Jin; Zhu, Changbin; Su, Chunxia
